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A conserved response to stress involves endonucleolytic cleavage of cytoplasmic transfer RNAs 
(tRNAs) by ribonucleases that are normally secreted or sequestered. Ribonuclease activation or 
release is an intriguing new aspect of cellular stress responses, with a potential impact on transla-
tion, apoptosis, cancer, and disease progression.Eukaryotic cells contain robust mecha-
nisms to respond to and mitigate environ-
mental stress. These responses include 
neutralization of stress stimuli, repair of 
cellular damage, and induction of cell 
death pathways. One important compo-
nent of stress responses is the regulation 
of RNA metabolism, which often involves 
a decrease in general translation and an 
increase in preferential translation of 
stress-response genes (reviewed in Hol-
cik and Sonenberg, 2005).
Transfer RNAs (tRNAs) are a fundamen-
tal component of the translation machin-
ery but also play roles in modulating 
cell proliferation and stress responses. 
For example, overexpression of initiator 
tRNAs contributes to cellular transforma-
tion (Marshall et al., 2008). Additionally, 
during amino acid starvation, uncharged 
tRNAs act as signaling molecules to acti-
vate the Gcn2 kinase, which modulates 
the starvation response (Wek et al., 1995). 
Moreover, during stress responses, tRNA 
transcription is downregulated, and there 
is retrograde transport of tRNAs into the 
nucleus (Hopper and Shaheen, 2008).
Several observations now indicate 
that tRNAs can be endonucleolytically 
cleaved, primarily in the anticodon loop, 
under a variety of stress conditions. The 
nucleases responsible for stress-induced 
tRNA cleavage in yeast (Rny1) and mam-
malian cells (angiogenin) are secreted or 
sequestered proteins that gain access to 
cytosolic tRNAs during stress. New work 
suggests that cleaved tRNAs may inhibit 
translation or may target specific mRNAs 
for degradation. Moreover, Rny1 and its 
human ortholog RNASET2 promote cell 
death and limit tumor formation in a man-
ner that is independent of their nuclease 
activity, suggesting that they may also 
serve as sensors of cellular damage.tRNAs Are Cleaved during Stress
The earliest reports of tRNA cleav-
age come from work in the bacterium 
Escherichia coli on the nuclease PrrC. 
This nuclease cleaves tRNAs in their 
anticodon loop, destroying full-length 
tRNAs in response to bacteriophage 
infection (Levitz et al., 1990). Anti-
codon-loop cleavage of specific tRNAs 
also occurs in cells targeted in trans by 
colicin D or E5, resulting in cell death 
from translational arrest. Cytotoxic 
colicins are normally used as a defense 
mechanism against competing organ-
isms (Masaki and Ogawa, 2002).
Cleavage of tRNAs within the anti-
codon loop has now been reported 
during a variety of stress responses 
in eukaryotic cells (Table S1 available 
online). For example, tRNA cleavage 
occurs during amino acid starvation 
in the unicellular organism Tetrahy-
mena (Lee and Collins, 2005) and in 
human, plant, and Saccharomyces 
cerevisiae (budding yeast) systems 
during oxidative stress (Thompson 
et al., 2008; Yamasaki et al., 2009). 
Starvation-induced hyphae formation 
in the bacterium Streptomyces coeli-
color correlates with the production of 
tRNA fragments (Haiser et al., 2008), 
and cleaved tRNAs are also observed 
in the primitive eukaryote Giardia dur-
ing starvation-induced encystation (Li 
et al., 2008). Several large-scale small 
RNA sequencing projects have demon-
strated the presence of half tRNAs in 
various organisms, including the fruit 
fly Drosophila (Aravin et al., 2003) and 
the fungus Aspergillus (Jochl et al., 
2008), and in human cell lines (Kawaji 
et al., 2008). tRNA halves are also 
found in pumpkin phloem sap (Zhang 
et al., 2009). Taken together, these Celobservations demonstrate that tRNA 
fragments are present in a wide variety 
of organisms and often increase dur-
ing stress conditions. Notably, stress-
induced cleavage of tRNAs is not a 
mechanism to degrade misprocessed 
or hypomodified tRNAs. Such tRNAs 
are primarily degraded 5′ to 3′ in the 
cytosol or adenylated and degraded 3′ 
to 5′ in the nucleus (Chernyakov et al., 
2008; Copela et al., 2008); yeast strains 
with aberrant tRNAs do not show an 
increase in tRNA fragments (Thomp-
son et al., 2008).
Although these observations come 
from numerous organisms, they have 
several common features. First, cleav-
age is not limited to specific tRNAs, as 
sequencing and northern blot analyses 
have shown that many tRNAs undergo 
endonucleolytic cleavage, although the 
relative amount of cleavage can differ 
(Fu et al., 2009; Haiser et al., 2008; 
Jochl et al., 2008; Kawaji et al., 2008; 
Lee and Collins, 2005; Li et al., 2008; 
Thompson et al., 2008; Yamasaki et 
al., 2009). In contrast, colicin-mediated 
cleavage tends to target specific tRNAs 
(Masaki and Ogawa, 2002). Second, 
cleavage occurs primarily in the anti-
codon loop, though cleavage in other 
loops has been observed (Kawaji et al., 
2008; Lee and Collins, 2005; Li et al., 
2008; Thompson et al., 2008; Zhang 
et al., 2009) (Table S1). Given that the 
tRNA cleavage enzymes have broad 
specificity (see below), the anticodon 
loop is likely targeted because it is the 
most accessible region of the tRNA. 
Third, in most cases, full-length tRNA 
levels do not decline significantly, and 
tRNA fragment levels are consistently 
lower than those of full-length tRNAs 
(Lee and Collins, 2005; Thompson et l 138, July 24, 2009 ©2009 Elsevier Inc. 215
Figure 1. Stress-Induced tRNA Cleavage
Stress conditions induce the release of sequestered ribonucleases (RNases): angiogenin in mammalian cells (left) and Rny1 in yeast (right). The RNases move 
into the cytoplasm where they cleave tRNAs into fragments. There are several potential mechanisms by which cleaved or nicked tRNAs might inhibit mRNA 
function. For example, nicked tRNAs might activate a stress response or stall elongation by interacting with the translation machinery. tRNA fragments could 
interact either with an unknown general repression complex or with known complexes such as Argonaute or Piwi to inhibit translation. tRNA fragments may 
also direct cleavage of specific mRNAs in conjunction with tRNA processing or Argonaute complexes.al., 2008; Yamasaki et al., 2009), sug-
gesting that only a small proportion of 
tRNA is targeted. This is in contrast to 
the complete depletion of tRNAs tar-
geted by colicins (Masaki and Ogawa, 
2002). Fourth, fragments are likely 
to derive from fully mature tRNAs, as 
sequencing indicates that tRNA frag-
ments do not contain introns, have 
mature 5′ ends, and often include 3′ 
CCA or partial CCA sequences (Haiser 
et al., 2008; Kawaji et al., 2008; Lee and 
Collins, 2005; Li et al., 2008; Thompson 
et al., 2008; Zhang et al., 2009).
Cleavage of tRNAs is not induced by 
all stress conditions. Cleavage was not 
induced in γ-irradiated (Fu et al., 2009), 
etoposide-treated (Yamasaki et al., 
2009), or caffeine-treated (Thompson et 
al., 2008; Yamasaki et al., 2009) human 
cells, or in yeast cells undergoing amino 
acid or glucose starvation or UV irradia-
tion (Thompson et al., 2008). The failure 
of these stress stimuli to increase tRNA 
fragment levels indicates that cleav-
age is neither a general consequence 
of all stresses nor a general effect of a 216 Cell 138, July 24, 2009 ©2009 Elsevier Idecrease in translation rates. However, 
a low level of cleavage may occur even 
in the absence of stress, as some tRNA 
cleavage is observed in unstressed 
yeast cells (Thompson et al., 2008).
Stress-induced cleavage is not lim-
ited to tRNAs. In yeast, specific ribo-
somal RNA (rRNA) fragments also 
increase during stress (Thompson et al., 
2008), and sequence analysis indicates 
that fragments of other RNAs are pres-
ent in small RNA populations (Table S1). 
Given that rRNA and tRNA species can 
be affected by this cleavage mecha-
nism, one anticipates that some mRNAs 
will also be subjected to stress-induced 
endonucleolytic cleavage.
Stress-Activated Nucleases
The nucleases responsible for tRNA 
cleavage during stress have been 
identified in budding yeast and mam-
malian cells (Figure 1). In yeast, tRNAs 
are cleaved by Rny1, a member of 
the RNase T2 family (Thompson and 
Parker, 2009). Although mammalian 
cells do contain an ortholog of Rny1 nc.called RNASET2, this nuclease does 
not affect tRNA cleavage during oxida-
tive stress in mammalian cells (Thomp-
son and Parker, 2009; Yamasaki et al., 
2009). Instead, stress-induced tRNA 
cleavage in mammalian cells depends 
on angiogenin, a member of the RNase 
A family (Fu et al., 2009; Yamasaki et 
al., 2009). Ribonucleases from the 
RNase T2 and RNase A families typi-
cally have little substrate specificity, 
suggesting that angiogenin and Rny1 
might cleave additional RNAs during 
stress. Consistent with this view, Rny1 
affects rRNA cleavage during stress in 
budding yeast (Thompson and Parker, 
2009), and angiogenin is known to 
cleave both tRNAs and rRNAs (Saxena 
et al., 1992; St Clair et al., 1988).
A surprising property of both Rny1 
and angiogenin is that these nucle-
ases are either secreted or targeted 
to membrane-bound organelles and 
thus are normally segregated from 
cytoplasmic RNAs. Specifically, Rny1 
is both secreted (MacIntosh et al., 
2001) and localized to the vacuole (the 
yeast equivalent of the lysosome). Dur-
ing oxidative stress, Rny1 and other 
vacuolar proteins appear to exit the 
vacuole and move into the cytoplasm 
via an unknown mechanism, allowing 
access to cytosolic RNAs (Thompson 
and Parker, 2009). Angiogenin is also a 
secreted protein but is known to enter 
cells by endocytosis. It is concentrated 
in the nucleus/nucleolus (Moroianu 
and Riordan, 1994) and is also found 
in the cytoplasm, where it is bound 
by the ribonuclease inhibitor RNH1 
(Shapiro and Vallee, 1987; Tsuji et al., 
2005). Consistent with cytoplasmic 
angiogenin being responsible for tRNA 
cleavage, RNH1 depletion increases 
tRNA fragment production (Yamasaki 
et al., 2009). This suggests that stress 
conditions may activate angiogenin by 
promoting either its dissociation from 
RNH1 or its release from the nuclear 
compartment. Therefore, a common 
theme is that these nucleases are nor-
mally secreted or sequestered and 
then enter the cytosol during stress. 
This resembles a process in stressed 
mammalian cells in which several lyso-
somal proteases exit the lysosome as 
initiators or executors of the apoptotic 
response (Guicciardi et al., 2004). The 
release of ribonucleases from seques-
tration may be an important aspect of 
the stress response, not only because 
these nucleases can cleave cytosolic 
RNAs but also because their release 
may be a marker of cellular damage.
Biological Roles of Cleaved RNAs
Cleavage of RNAs during stress has 
several potential consequences. For 
instance, tRNA cleavage could inhibit 
translation by depletion of the tRNA 
pool. However, full-length tRNA is not 
significantly depleted in any of the 
studies published to date, regard-
less of tRNA fragment levels (Fu et 
al., 2009; Haiser et al., 2008; Lee and 
Collins, 2005; Li et al., 2008; Thomp-
son et al., 2008; Yamasaki et al., 2009; 
Zhang et al., 2009). Even in Aspergillus, 
where full-length tRNA levels fluctuate 
over time, tRNAs do not disappear, and 
their decline does not correspond with 
higher levels of tRNA fragments (Jochl 
et al., 2008). Thus, stress-induced tRNA 
cleavage is unlikely to be a mechanism 
for depletion of cellular tRNA pools.Some evidence suggests that 
cleaved tRNAs themselves may func-
tion to inhibit translation. For example, 
Zhang et al. (2009) demonstrated that 
small RNAs in phloem sap—which 
include many tRNA halves—inhibit 
translation of several mRNAs in vitro. To 
determine whether this was an effect of 
tRNA fragments or other species in the 
phloem small RNA pool, they treated 
yeast tRNA with RNase A (to achieve 
partial cleavage) and showed that these 
cleaved tRNAs also repressed transla-
tion in vitro. Strikingly, denaturation of 
the RNase A-treated tRNAs prevented 
the inhibition of translation (Zhang et 
al., 2009). This suggests that transla-
tion was inhibited by fully folded tRNA 
with a nick in the anticodon loop, not 
by separated half tRNAs. Such nicked 
tRNAs would be more likely than tRNA 
fragments to associate with the trans-
lation machinery, form effective blocks 
to elongation or initiation, activate the 
GCN2 stress response, or impair the 
function of proteins that normally bind 
to tRNAs (Figure 1).
Additional experiments suggest 
that tRNA fragments might also have 
a biological function. For example, 
Yamasaki et al. (2009) demonstrated 
that 5′ tRNA half molecules can inhibit 
protein synthesis, both in vitro and 
when transfected into mouse or human 
cells. Although the decrease in overall 
protein synthesis was small, transfec-
tion of 3′ tRNA halves did not show a 
similar effect, suggesting that this was 
a specific effect and that 5′ halves 
may preferentially affect translational 
repression. These exciting data are 
tempered with the caveat that the 5′ 
tRNA halves used for transfection were 
a pool of gel-purified small RNAs from 
stressed mammalian cells in culture 
and may contain small RNAs that do 
not originate from tRNAs (Yamasaki et 
al., 2009).
There are several possible mecha-
nisms by which tRNA fragments might 
inhibit translation (Figure 1). One possi-
bility is that they interact with unknown 
proteins to form a repression complex. 
Alternatively, they may serve as unique 
substrates for known pathways. tRNA 
fragments have been identified in pools 
of small RNAs copurifying with Argo-
naute and Piwi complexes (Kawamura Celet al., 2008; Lau et al., 2006), suggest-
ing that such tRNA fragments could 
function as siRNAs or miRNAs. Another 
intriguing possibility is that tRNA frag-
ments guide cleavage and destruction 
of specific mRNAs by recruiting tRNA 
processing enzymes to mRNAs. Both 
tRNase Z, a 3′ pre-tRNA processing 
enzyme, and RNase P, which processes 
the 5′ ends of pre-tRNAs, can cleave 
RNAs containing artificial pre-tRNA-
like structures composed of engineered 
partial tRNA fragments base-paired to 
mRNAs (Nashimoto, 2000; Yuan et al., 
1992) (Figure 1). Strikingly, new work 
suggests that endogenous half tRNAs 
can guide tRNase Z-mediated cleav-
age of engineered target sequences 
and potentially of endogenous targets 
in vivo (Elbarbary et al., 2009). Taken 
together, these observations build a 
view that either nicked tRNA molecules 
or tRNA fragments may inhibit global 
translation or affect the degradation 
or repression of specific mRNAs. An 
important goal of future work will be to 
determine the mechanisms by which 
nicked tRNAs or tRNA fragments affect 
mRNA function.
RNA Cleavage and the Stress 
Response
Stress-induced release of RNases into 
the cytosol may modulate the stress 
response in several ways. First, cleav-
age of tRNAs, and potentially rRNAs, 
may inhibit specific steps in translation, 
leading to a global decrease in transla-
tion. Importantly, general inhibition of a 
specific aspect of translation can lead 
to preferential translation of specific 
mRNAs, as individual mRNAs have dif-
ferent rate-limiting steps during trans-
lation. For example, cleavage of tRNAs 
by angiogenin might decrease general 
translation but upregulate translation of 
IRES-containing mRNAs such as that 
encoding vascular endothelial growth 
factor (VEGF), which promotes new 
blood vessel formation (angiogenesis) 
(Holcik and Sonenberg, 2005). Alter-
natively, cytosolic Rny1 or angiogenin 
might directly cleave specific mRNAs 
or produce tRNA fragments that tar-
get specific mRNAs in conjunction with 
tRNA processing enzymes or Argo-
naute proteins. Finally, the activation 
of these nucleases during stress may l 138, July 24, 2009 ©2009 Elsevier Inc. 217
provide a new paradigm for intercel-
lular communication during stress. For 
example, treatment of cultured mam-
malian cells with angiogenin stimulates 
tRNA cleavage (Yamasaki et al., 2009) 
and with exogenous RNASET2 affects 
growth (Smirnoff et al., 2006).
Rny1 and RNASET2 also have a role 
in the stress response that is indepen-
dent of their nucleolytic activity. Specifi-
cally, overexpression of the RNY1 gene 
reduces cell viability, especially during 
oxidative stress. Also, RNY1 has genetic 
interactions with genes involved in the 
oxidative stress response and apoptosis 
in yeast (Thompson and Parker, 2009). 
Intriguingly, this effect of Rny1 on cell 
survival is independent of its catalytic 
activity, arguing that Rny1 has a sec-
ond function involving promotion of cell 
death during stress that is separate from 
its ability to cleave RNA (Thompson and 
Parker, 2009). A possible explanation is 
that upon release to the cytosol, Rny1 
promotes cell death by direct interac-
tions with components of an unknown 
pathway. Strikingly, expression of the 
Rny1 homolog RNASET2, or treatment 
with recombinant RNASET2 protein, 
inhibits colony formation and metasta-
sis of tumor cell lines in a manner that is 
independent of the catalytic activity of 
RNASET2 (Acquati et al., 2005; Smirnoff 
et al., 2006). Thus, detection of Rny1, 
and possibly its orthologs, in the cyto-
sol may be a conserved mechanism for 
assessing damage and modulating cell 
survival following stress, analogous to 
the role of mitochondrial cytochrome c 
in promoting apoptosis.
Several observations suggest that 
stress-induced RNA cleavage and 
release of RNases into the cytosol 
may be involved in cancer and other 
diseases. First, as discussed above, 
the Rny1 homolog RNASET2 reduces 
the metastatic potential of tumor cell 
lines both in vitro and in vivo (Acquati 
et al., 2005; Smirnoff et al., 2006). 
Oxidative stress in mammalian cells 
causes release of lysosomal proteins 
into the cytosol, which is thought to 
promote apoptosis (reviewed in Guic-
ciardi et al., 2004). Proton-pump inhibi-
tors have proven effective for inducing 
apoptosis in human tumor cells both 
in vitro and ex vivo by a mechanism 
involving increased permeability of 218 Cell 138, July 24, 2009 ©2009 Elsevier Ithe lysosomal membrane (De Milito 
et al., 2007). Second, antagonists of 
angiogenin can delay or prevent tumor 
development in vivo (e.g., Olson et al., 
1995), and angiogenin mutations (many 
leading to reduced RNase activity) have 
recently been found in patients with 
amyotrophic lateral sclerosis (Crabtree 
et al., 2007). Third, tRNA fragments—
identified by detection of modified 
ribonucleosides—have been reported 
in the serum and urine of humans and 
mice with certain tumors (Borek et al., 
1977; Speer et al., 1979), suggesting 
that tRNA cleavage occurs in tumors 
in situ. Finally, Onconase, an RNase A 
family member in clinical trials, is toxic 
to human cancer cells in culture at 
least in part due to its ability to cleave 
tRNAs (Ardelt et al., 1991; Iordanov et 
al., 2000). These observations suggest 
that understanding the mechanisms 
and roles of RNA cleavage during 
stress may lead to the development of 
new therapies for treating cancer and 
possibly other diseases.
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